General Information
Version
DRE-C13084280 - Doxycycline hyclate
Revision date
2022-05-26
Product name
Doxycycline hyclate
Substance name
C22 H25 Cl N2 O8
CAS No.
24390-14-5
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC Limited
Emergency telephone
1-800-424-9300, +1 703-741-5970
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H317, H319, H335, H336, H361, H362
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
2.2 Label elements
-
Contains
Doxycycline hyclate
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed H315 - Causes skin irritation H317 - May cause an allergic skin reaction H319 - Causes serious eye irritation H335 - May cause respiratory irritation H336 - May cause drowsiness or dizziness H361 - Suspected of damaging fertility or the unborn child H362 - May cause harm to breast-fed children
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves/protective clothing/eye protection/face protection P501 - Dispose of contents/ container to an approved waste disposal plant
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 4 - (H302) Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2 - (H319) Skin sensitisation Category 1 - (H317) Reproductive toxicity Category 2 - (H361) Effects on or via lactation Yes - (H362) Category 3 Narcotic effects, Respiratory irritation
